Literature DB >> 10424888

Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum.

A E Biemer-Hüttmann1, M D Walsh, M A McGuckin, Y Ajioka, H Watanabe, B A Leggett, J R Jass.   

Abstract

We studied the distribution of the four human apomucins MUC1, MUC2, MUC4, and MUC5AC in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum using immunohistochemical techniques, with the aim of comparing and contrasting their patterns of expression. A series of 12 hyperplastic polyps, 27 serrated adenomas, and 20 traditional adenomas was studied. No significant change in apomucin expression was observed in traditional adenomas compared with normal colorectal epithelium, except for MUC5AC, which was present in 12 of the adenomas (60%) and only 20% of the normal samples. In both hyperplastic polyps and serrated adenomas, MUC2 and MUC5AC mucin expression was consistently and markedly increased. In 50% of the hyperplastic polyps, MUC4 was reduced but in the remaining cases was similar to normal. Loss of MUC4 expression was observed in all serrated adenomas. MUC1 was not increased in the hyperplastic polyps but increased expression was seen in 17 of the serrated adenomas (63%). Similar altered distribution patterns of MUC2, MUC4, and MUC5AC were seen in hyperplastic polyps and serrated adenomas, whereas traditional adenomas showed little change from normal patterns of expression. Although hyperplastic polyps are commonly defined as benign lesions without neoplastic potential, the similar phenotypes of hyperplastic and serrated adenomas and the existence of mixed polyps suggest that these lesions may represent a histogenetic continuum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424888     DOI: 10.1177/002215549904700808

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  45 in total

Review 1.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.

Authors:  A P Corfield; N Myerscough; R Longman; P Sylvester; S Arul; M Pignatelli
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer.

Authors:  Ann Willman Silk; Robert E Schoen; Douglas M Potter; Olivera J Finn
Journal:  Mol Immunol       Date:  2009-02-13       Impact factor: 4.407

3.  Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma.

Authors:  John J Liang; Sadir Alrawi; Dongfeng Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

4.  Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.

Authors:  A Lugli; I Zlobec; K Baker; P Minoo; L Tornillo; L Terracciano; J R Jass
Journal:  J Clin Pathol       Date:  2006-06-30       Impact factor: 3.411

5.  Diversity of mucins in labial glands of infants.

Authors:  Mechthild Stoeckelhuber; Marco R Kesting; Denys J Loeffelbein; Christoph Schmitz; Klaus-Dietrich Wolff
Journal:  Histol Histopathol       Date:  2020-03-12       Impact factor: 2.303

6.  Poorly differentiated adenocarcinoma of the colon: subsite location and clinicopathologic features.

Authors:  Yasuo Imai
Journal:  Int J Colorectal Dis       Date:  2014-11-23       Impact factor: 2.571

7.  Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon.

Authors:  R G Hardy; C Tselepis; J Hoyland; Y Wallis; T P Pretlow; I Talbot; D S A Sanders; G Matthews; D Morton; J A Z Jankowski
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

8.  Mucin gene expression in the ileoanal reservoir is altered and may be relevant to the risk of inflammation and dysplasia.

Authors:  P A Sylvester; M Walsh; N Myerscough; B F Warren; A P Corfield; M G Thomas; P Durdey
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis.

Authors:  Rodrigo Oliva Perez; Bárbara Helou Bresciani; Cláudio Bresciani; Igor Proscurshim; Desiderio Kiss; Joaquim Gama-Rodrigues; Diego Daniel Pereira; Viviane Rawet; Ivan Cecconnello; Angelita Habr-Gama
Journal:  Int J Colorectal Dis       Date:  2008-05-06       Impact factor: 2.571

10.  Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?

Authors:  Mahsa Molaei; Babak Khoshkrood Mansoori; Reza Mashayekhi; Mohsen Vahedi; Mohamad Amin Pourhoseingholi; Seyed Reza Fatemi; Mohammad Reza Zali
Journal:  BMC Cancer       Date:  2010-10-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.